NASDAQ:GILD (Gilead Sciences)
About GILD
Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide.
Gilead Sciences (NASDAQ: GILD) Latest News
![question marks written reminders tickets](https://www.fool.ca/wp-content/uploads/2018/09/Questions-400x225.jpg)
Coronavirus
Will Remdesivir Save the Economy — and the World?
![Modern buildings in business district](https://www.fool.ca/wp-content/uploads/2019/04/Skyscrapers-400x225.jpg)
Investing
Coronavirus Fears Make This Stock a Winner
![](https://www.fool.ca/wp-content/uploads/2019/09/test-tubes-biotech-research-medical-medicine-healthcare-170x225.jpg)
Tech Stocks
Is iShares Nasdaq Biotechnology Index Fund a Buy?
![](https://www.fool.ca/wp-content/uploads/2016/01/Sale-16-9-400x225.jpg)